Xeris Biopharma Holdings Statistics

Total Valuation

XERS has a market cap or net worth of $1.33 billion. The enterprise value is $1.47 billion.

Market Cap	1.33B
Enterprise Value	1.47B

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

XERS has 172.64 million shares outstanding. The number of shares has increased by 19.55% in one year.

Current Share Class	172.64M
Shares Outstanding	172.64M
Shares Change (YoY)	+19.55%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	62.33%
Float	166.69M

Valuation Ratios

The trailing PE ratio is 119.96 and the forward PE ratio is 60.69.

PE Ratio	119.96
Forward PE	60.69
PS Ratio	4.22
Forward PS	3.25
PB Ratio	101.99
P/TBV Ratio	n/a
P/FCF Ratio	27.94
P/OCF Ratio	27.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.67, with an EV/FCF ratio of 31.03.

EV / Earnings	122.79
EV / Sales	4.68
EV / EBITDA	30.67
EV / EBIT	41.07
EV / FCF	31.03

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 19.87.

Current Ratio	2.12
Quick Ratio	1.42
Debt / Equity	19.87
Debt / EBITDA	4.61
Debt / FCF	5.44
Interest Coverage	1.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	6.34%
Return on Invested Capital (ROIC)	8.88%
Return on Capital Employed (ROCE)	13.13%
Weighted Average Cost of Capital (WACC)	9.12%
Revenue Per Employee	$723,800
Profits Per Employee	$27,605
Employee Count	435
Asset Turnover	0.89
Inventory Turnover	0.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.27% in the last 52 weeks. The beta is 0.90, so XERS's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	+63.27%
50-Day Moving Average	6.41
200-Day Moving Average	7.03
Relative Strength Index (RSI)	77.13
Average Volume (20 Days)	1,981,597

Short Selling Information

The latest short interest is 12.51 million, so 7.25% of the outstanding shares have been sold short.

Short Interest	12.51M
Short Previous Month	12.36M
Short % of Shares Out	7.25%
Short % of Float	7.51%
Short Ratio (days to cover)	7.27

Income Statement

In the last 12 months, XERS had revenue of $314.85 million and earned $12.01 million in profits. Earnings per share was $0.06.

Revenue	314.85M
Gross Profit	270.44M
Operating Income	35.90M
Pretax Income	12.01M
Net Income	12.01M
EBITDA	48.08M
EBIT	35.90M
Earnings Per Share (EPS)	$0.06

Full Income Statement

Balance Sheet

The company has $111.75 million in cash and $258.55 million in debt, giving a net cash position of -$146.80 million or -$0.85 per share.

Cash & Cash Equivalents	111.75M
Total Debt	258.55M
Net Cash	-146.80M
Net Cash Per Share	-$0.85
Equity (Book Value)	13.01M
Book Value Per Share	0.08
Working Capital	133.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $48.53 million and capital expenditures -$1.01 million, giving a free cash flow of $47.52 million.

Operating Cash Flow	48.53M
Capital Expenditures	-1.01M
Depreciation & Amortization	12.18M
Net Borrowing	n/a
Free Cash Flow	47.52M
FCF Per Share	$0.28

Full Cash Flow Statement

Margins

Gross margin is 85.89%, with operating and profit margins of 11.40% and 3.81%.

Gross Margin	85.89%
Operating Margin	11.40%
Pretax Margin	3.81%
Profit Margin	3.81%
EBITDA Margin	15.27%
EBIT Margin	11.40%
FCF Margin	15.09%

Dividends & Yields

XERS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.55%
Shareholder Yield	-19.55%
Earnings Yield	0.90%
FCF Yield	3.58%

Analyst Forecast

The average price target for XERS is $11.29, which is 46.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.29
Price Target Difference	46.81%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	22.95%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XERS has an Altman Z-Score of 0.79 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	7